Stanford University: Carcinoma, Hepatocellular trials

The registry lists 12 Carcinoma, Hepatocellular studies with Stanford University as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 2Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial ChemoembolizationTerminatedNCT02762266Phase 3Results posted
• [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver CancerCompletedNCT02695628Phase 2Results posted
• Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response EvaluationCompletedNCT02424955Not applicableResults posted
• Combination SBRT With TACE for Unresectable Hepatocellular CarcinomaTerminatedNCT01020812Phase 1/2Results posted
• Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging GuidanceCompletedNCT00926536Not applicableResults posted
• B-mode Ultrasound Imaging in Detecting Early Liver CancerCompletedNCT02774161Not applicable
• Epidemiologic Study of Hepatocellular Carcinoma in the USCompletedNCT02358070
• Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular CarcinomaTerminatedNCT01326390
• A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular CarcinomaApproved for marketingNCT01076517
• Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular CancerCompletedNCT01034865
• Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular CarcinomaTerminatedNCT00767936
• Permission to Collect Blood Over Time for ResearchTerminatedNCT00767234